Breaking Barriers Inside and Outside of Clinical Trials


Otis Johnson, PhD, Vice President, Product Line Executive; Chief Diversity, Inclusion and Sustainability Officer, at Clario discusses key changes in the industry that have had the greatest impact, Clario’s first ESG report, and how DE&I initiatives will evolve.

© 2024 MJH Life Sciences

All rights reserved.